Univo Pharmaceuticals (XTAE:UNVO-M) Interest Expense : ₪-4.64 Mil (TTM As of Jun. 2022)

View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Univo Pharmaceuticals's interest expense for the three months ended in Jun. 2022 was ₪ -1.06 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2022 was ₪-4.64 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Univo Pharmaceuticals's Operating Income for the three months ended in Jun. 2022 was ₪ -20.94 Mil. Univo Pharmaceuticals's Interest Expense for the three months ended in Jun. 2022 was ₪ -1.06 Mil. Univo Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Univo Pharmaceuticals Interest Expense Historical Data

The historical data trend for Univo Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals Interest Expense Chart

Univo Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Interest Expense

Get a 7-Day Free Trial

-0.24

-0.43

-1.72

-3.74

Univo Pharmaceuticals Quarterly Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Interest Expense	Get a 7-Day Free Trial													-0.53	-1.47	-0.91	-1.21	-1.06

Univo Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-4.64 Mil.

Univo Pharmaceuticals (XTAE:UNVO-M) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Univo Pharmaceuticals's Interest Expense for the three months ended in Jun. 2022 was ₪-1.06 Mil. Its Operating Income for the three months ended in Jun. 2022 was ₪-20.94 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2022 was ₪29.67 Mil.

Univo Pharmaceuticals's Interest Coverage for the quarter that ended in Jun. 2022 is calculated as

Univo Pharmaceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Univo Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harshar 20, Ashkelon, ISR, 7878329

Website

https://www.univopharma.com

Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines